S&P 500   4,967.23
DOW   37,986.40
QQQ   416.60
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
S&P 500   4,967.23
DOW   37,986.40
QQQ   416.60
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
S&P 500   4,967.23
DOW   37,986.40
QQQ   416.60
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
S&P 500   4,967.23
DOW   37,986.40
QQQ   416.60
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro

NexPoint Residential Trust (NXRT) Stock Forecast & Price Target

$32.11
+0.78 (+2.49%)
(As of 04/19/2024 06:40 PM ET)

NexPoint Residential Trust Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 5 Analyst Ratings

Analysts' Consensus Price Target

$37.25
16.01% Upside
High Forecast$40.00
Average Forecast$37.25
Low Forecast$35.00
TypeCurrent Forecast
4/23/23 to 4/22/24
1 Month Ago
3/24/23 to 3/23/24
3 Months Ago
1/23/23 to 1/23/24
1 Year Ago
4/23/22 to 4/23/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
4 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$37.25$38.50$43.67$60.20
Predicted Upside16.01% Upside16.52% Upside16.01% Upside28.57% Upside
Get NexPoint Residential Trust Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NXRT and its competitors with MarketBeat's FREE daily newsletter.

NXRT Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NXRT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

NexPoint Residential Trust Stock vs. The Competition

TypeNexPoint Residential TrustFinance CompaniesS&P 500
Consensus Rating Score
2.20
2.44
2.49
Consensus RatingHoldHoldHold
Predicted Upside16.01% Upside78.06% Upside11.94% Upside
News Sentiment RatingVery Positive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/9/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$37.00 ➝ $35.00+5.33%
3/18/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeMarket Perform ➝ Underperform
3/6/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Outperform ➝ Market Outperform$40.00+34.36%
1/30/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$38.00+17.79%
12/20/2023Janney Montgomery Scott
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$36.00+3.60%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 08:47 AM ET.

NXRT Price Target - Frequently Asked Questions

What is NexPoint Residential Trust's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for NexPoint Residential Trust stock is Hold based on the current 1 sell rating, 2 hold ratings and 2 buy ratings for NXRT. The average twelve-month price prediction for NexPoint Residential Trust is $37.25 with a high price target of $40.00 and a low price target of $35.00. Learn more on NXRT's analyst rating history.

Do Wall Street analysts like NexPoint Residential Trust more than its competitors?

Analysts like NexPoint Residential Trust less than other Finance companies. The consensus rating score for NexPoint Residential Trust is 2.20 while the average consensus rating score for finance companies is 2.44. Learn more on how NXRT compares to other companies.

Is NexPoint Residential Trust being downgraded by Wall Street analysts?

Over the previous 90 days, NexPoint Residential Trust's stock had 1 downgrade by analysts.

Does NexPoint Residential Trust's stock price have much upside?

According to analysts, NexPoint Residential Trust's stock has a predicted upside of 14.61% based on their 12-month stock forecasts.

What analysts cover NexPoint Residential Trust?

NexPoint Residential Trust has been rated by Deutsche Bank Aktiengesellschaft, JMP Securities, Raymond James, and Truist Financial in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:NXRT) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners